Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Sales

Stoke Therapeutics (STOK) Return on Assets: 2022-2025

Historic Return on Assets for Stoke Therapeutics (STOK) over the last 3 years, with Sep 2025 value amounting to 0.11%.

  • Stoke Therapeutics' Return on Assets rose 46.00% to 0.11% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.11%, marking a year-over-year increase of 46.00%. This contributed to the annual value of -0.36% for FY2024, which is 8.00% up from last year.
  • As of Q3 2025, Stoke Therapeutics' Return on Assets stood at 0.11%, which was down 17.96% from 0.13% recorded in Q2 2025.
  • Stoke Therapeutics' 5-year Return on Assets high stood at 0.15% for Q1 2025, and its period low was -0.50% during Q1 2024.
  • Moreover, its 3-year median value for Return on Assets was -0.37% (2023), whereas its average is -0.26%.
  • In the last 5 years, Stoke Therapeutics' Return on Assets dropped by 13bps in 2024 and then skyrocketed by 65bps in 2025.
  • Stoke Therapeutics' Return on Assets (Quarterly) stood at -0.38% in 2022, then declined by 7bps to -0.45% in 2023, then grew by 13bps to -0.32% in 2024, then surged by 46bps to 0.11% in 2025.
  • Its Return on Assets stands at 0.11% for Q3 2025, versus 0.13% for Q2 2025 and 0.15% for Q1 2025.